Maryland Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.13M | Buy |
9,694
+80
| +0.8% | +$25.3K | 0.26% | 70 |
|
|
2022
Q2 | $3.12M | Sell |
9,614
-609
| -6% | -$183K | 0.25% | 69 |
|
|
2022
Q1 | $2.93M | Sell |
10,223
-4,914
| -32% | -$1.26M | 0.18% | 74 |
|
|
2021
Q4 | $4.18M | Sell |
15,137
-1,034
| -6% | -$262K | 0.23% | 66 |
|
|
2021
Q3 | $3.74M | Sell |
16,171
-16,408
| -50% | -$4.05M | 0.22% | 69 |
|
|
2021
Q2 | $7.48M | Sell |
32,579
-7,037
| -18% | -$1.41M | 0.45% | 55 |
|
|
2021
Q1 | $7.4M | Buy |
39,616
+634
| +2% | +$124K | 0.49% | 53 |
|
|
2020
Q4 | $6.58M | Buy |
38,982
+3,963
| +11% | +$592K | 0.46% | 52 |
|
|
2020
Q3 | $5.18M | Buy |
35,019
+967
| +3% | +$150K | 0.42% | 54 |
|
|
2020
Q2 | $5.59M | Sell |
34,052
-636
| -2% | -$97.6K | 0.52% | 53 |
|
|
2020
Q1 | $4.81M | Buy |
34,688
+1,849
| +6% | +$254K | 0.57% | 50 |
|
|
2019
Q4 | $4.32M | Buy |
32,839
+1,293
| +4% | +$150K | 0.46% | 54 |
|
|
2019
Q3 | $3.53M | Buy |
31,546
+775
| +3% | +$86.3K | 0.4% | 61 |
|
|
2019
Q2 | $3.41M | Sell |
30,771
-3,201
| -9% | -$377K | 0.4% | 59 |
|
|
2019
Q1 | $4.41M | Sell |
33,972
-983
| -3% | -$120K | 0.55% | 50 |
|
|
2018
Q4 | $4.04M | Buy |
34,955
+2,335
| +7% | +$261K | 0.58% | 47 |
|
|
2018
Q3 | $3.5M | Sell |
32,620
-915
| -3% | -$91.5K | 0.46% | 51 |
|
|
2018
Q2 | $2.86M | Sell |
33,535
-10
| -0% | -$821 | 0.4% | 56 |
|
|
2018
Q1 | $2.6M | Buy |
33,545
+10
| +0% | +$805 | 0.37% | 58 |
|
|
2017
Q4 | $2.83M | Sell |
33,535
-535
| -2% | -$45.5K | 0.42% | 52 |
|
|
2017
Q3 | $2.91M | Sell |
34,070
-25
| -0.1% | -$2.05K | 0.45% | 52 |
|
|
2017
Q2 | $2.81M | Sell |
34,095
-370
| -1% | -$30.2K | 0.4% | 53 |
|
|
2017
Q1 | $2.9M | Sell |
34,465
-975
| -3% | -$78.1K | 0.43% | 52 |
|
|
2016
Q4 | $2.61M | Sell |
35,440
-538
| -1% | -$40.1K | 0.4% | 53 |
|
|
2016
Q3 | $2.89M | Buy |
35,978
+435
| +1% | +$34.8K | 0.43% | 50 |
|
|
2016
Q2 | $2.8M | Buy |
35,543
+95
| +0.3% | +$7.15K | 0.44% | 48 |
|
|
2016
Q1 | $2.55M | Sell |
35,448
-5,405
| -13% | -$409K | 0.37% | 48 |
|
|
2015
Q4 | $3.44M | Sell |
40,853
-570
| -1% | -$47.3K | 0.51% | 41 |
|
|
2015
Q3 | $3.47M | Sell |
41,423
-1,695
| -4% | -$143K | 0.59% | 40 |
|
|
2015
Q2 | $3.6M | Buy |
43,118
+370
| +0.9% | +$28.2K | 0.56% | 39 |
|
|
2015
Q1 | $3.11M | Buy |
42,748
+1,435
| +3% | +$102K | 0.48% | 42 |
|
|
2014
Q4 | $2.85M | Buy |
41,313
+415
| +1% | +$28K | 0.47% | 45 |
|
|
2014
Q3 | $2.65M | Buy |
40,898
+2,050
| +5% | +$130K | 0.46% | 47 |
|
|
2014
Q2 | $2.42M | Buy |
38,848
+1,350
| +4% | +$80.5K | 0.42% | 50 |
|
|
2014
Q1 | $2.21M | Buy |
37,498
+1,610
| +4% | +$89.9K | 0.41% | 50 |
|
|
2013
Q4 | $1.83M | Buy |
35,888
+2,345
| +7% | +$117K | 0.29% | 63 |
|
|
2013
Q3 | $1.69M | Buy |
33,543
+2,105
| +7% | +$110K | 0.27% | 63 |
|
|
2013
Q2 | $1.54M | Buy |
+31,438
| New | +$1.71M | 0.27% | 68 |
|
Other funds holding LLY
Maryland Capital Management's LLY Position: Q3 2022 in Review
Maryland Capital Management increased its Eli Lilly (LLY) stake by 0.83% in Q3 2022, buying an estimated $25.3K and bringing the position to 9,694 shares worth $3.13M. The position accounts for 0.26% of the portfolio, ranked #70.
Maryland Capital Management first reported a position in LLY in Q2 2013 and has held it in 38 quarters since. The position peaked at $7.48M in Q2 2021. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.
- Maryland Capital Management held 9,694 shares of Eli Lilly worth $3.13M as of Q3 2022.
- Maryland Capital Management bought 80 Eli Lilly shares in Q3 2022, an estimated $25.3K.
- Eli Lilly made up 0.26% of Maryland Capital Management's portfolio in Q3 2022, its #70 holding.
- Maryland Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 38 quarters since.
- Maryland Capital Management's Eli Lilly position peaked at $7.48M in Q2 2021.
- 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.
Based on Maryland Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.